BackSummit Therapeutics Overview

Summit Therapeutics Total Assets

Summit Therapeutics's total assets is $750M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$752.18M
↑ 132.13% YoYΔ $428.15M vs prior year quarter

Peer trimmed avg / median

Loading

Summit Therapeutics Total Assets History

Loading

Summit Therapeutics vs. peers: Total Assets Comparison

Loading

Summit Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Summit Therapeutics (SMMT) FAQ

As of the most recent data (June 2026), SMMT shows a total assets of $750M. That compares with $320M in the prior-year period — up 132.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SMMT's total assets is now $750M (was $320M) — a 132.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Summit Therapeutics is outperforming or lagging.

Tracking SMMT's total assets over time shows whether Summit Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $750M That compares with $320M in the prior-year period — up 132.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Summit Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $750M) with ownership activity and broader fundamentals.